Subthalamic Nucleus, Akinesia and Parkinson's Disease

Recruiting N/A Interventional Study
Parkinson's Disease
Ready to participate?

Review the details below, then apply to join this clinical trial.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This program aims to understand the role of the subthalamic nucleus in the control of the movement in healthy humans and patients with Parkinson's disease, how the STN dysfunction contributes to akinesia and how the STN stimulation improves motor signs in PD patients .

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria for patients who will be operated 1. Diagnosis of idiopathic Parkinson's disease (according to the criteria of the United Kingdom Parkinson's Disease Society Brain Bank) 2. Age between 18 and 70; 3. Motor complications in the form of fluctuations in motor state or dyskinesias ind…
Contacts

Marie-Laure Welter, MD, PhD

marielaure.welter@icm-institute.org

CONTACT

Carine Karachi, MD, PhD

carine.karachi@gmail.com

CONTACT